Healthpeak: 3 Key Takeaways for Long-Term Investors

On its third quarter of 2026 earnings call, held on Nov. 3, 2026, Healthpeak (NYSE:DOC) announced that operational momentum allowed it to raise full-year earnings guidance by $0.05 per share. For long-term investors, that matters because property occupancy trends and disciplined balance sheet management directly dictate how durable a real estate dividend is over a multiyear holding period. Three things management said stand out.

1. Opportunistic Acquisitions Expand Core Life Science Footprint

Distressed valuations across commercial real estate are letting the company acquire lab buildings surrounding its existing campuses at steep discounts to replacement costs. These assets sit at just 41% occupancy today. But management projects they'll reach a stabilized yield of 9% to 10% as the company leverages its local scale to fill them.

Just kind of a unique point in time in life science in particular where we can buy assets that are cheap and strategic, and that is what we have done.
-- Scott Brinker, President, Chief Executive Officer

2. Life Science Occupancy Rebounds as Demand Diversifies

Total occupancy in the lab segment rose during the quarter as biotechnology funding recovered and nontraditional users entered the market. Artificial intelligence and robotics firms are now absorbing vacant space that features high ceiling clearances and heavy electric infrastructure.

Total occupancy increased 130 basis points last quarter and by 270 basis points year to date. Not sure anyone else in this sector could make that same claim.
-- Scott Brinker, President, Chief Executive Officer

3. Capital Recycling Recovers Equity for Higher-Yielding Investments

Healthpeak executed nearly $2 billion in outpatient asset sales, recapitalizations, and loan repayments to fund property reinvestment without issuing costly new shares. Recoveries from joint venture recapitalizations, which restructure property ownership with private institutional partners, let management recycle that cash into higher-yielding opportunities.

We're also happy to have closed nearly $2 billion of fully stabilized outpatient sales, recaps, and loan repayments earlier this year at a blended 6% cap rate.
-- Scott Brinker, President, Chief Executive Officer

Looking Ahead

Lab leasing velocity is picking up while senior housing occupancy expands alongside it, and scale in major research hubs and balance sheet liquidity give the company a structural advantage. And management continues to monitor refinancing costs on upcoming maturities.

We've said for a while we're going to be a consolidator. That's proving to be correct.
-- Scott Brinker, President, Chief Executive Officer

Clustering assets in established submarkets strengthens local leasing dominance and gives the company more pricing power over time.

When we acquire quality real estate in our core submarkets, there's a network effect that increases the value of our entire local footprint as we become the easy button for tenants and brokers.
-- Scott Brinker, President, Chief Executive Officer

The Motley Fool recommends Healthpeak Properties. The Motley Fool has a disclosure policy.